期刊文献+

舒尼替尼治疗恶性胰岛细胞瘤疗效初探 被引量:2

Therapeutic potential of sunitinib in the treatment of malignant islet cell tumor
原文传递
导出
摘要 恶性胰岛细胞瘤是一种少见但治疗效果欠佳的神经内分泌肿瘤.舒尼替尼作为新一代的酪氨酸激酶抑制剂,已被证实对于恶性胰岛细胞瘤具备较好的疗效. Malignant islet cell tumor, a rare type of neuroendocrine carcinoma, biologically behaves in an aggressive way and is difficulty to be treated. Sunitinib malate, a novel tyrosine kinase inhibitor, demonstrates a high efficacy in treating malignant islet cell tumor as shown by promising results in recent trials.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2011年第7期618-620,共3页 Chinese Journal of Endocrinology and Metabolism
关键词 舒尼替尼 恶性胰岛细胞瘤 Sunitinib malate Malignant islet cell tumor
  • 相关文献

参考文献30

  • 1Raoul JL, Niccoli P, Bang YJ. Sunitinib(SU) vs placebo for treatment of progressive, well-differentiated pancreatic islet cell tumours: results of a phase Ⅲ, randomised, double-blind triM. Eur J Cancer Suppl, 2009,7:361.
  • 2Oberg K, Eriksson B. Endocrine tumours of the pancreas. Best Pract Res Clin Gastroenterol, 2005,19:753-781.
  • 3Rinke A, Muller HH, Schade-Brittinger C, et al. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors : a report from the PROMID Study Group. J Clin Oncol, 2009,27:4656-4663.
  • 4Kwekkeboom DJ, de Herder WW, Kam BL, et al. Treatment with the radiolabeled somatostatin analog [ 177 Lu-DOTA 0, Tyr3 ] octreotate: toxicity, efficacy, and survival. J Clin Oncol, 2008,26:2124-2130.
  • 5Frank M, Klose K J, Wied M, et al. Combination therapy with octreotide and alpha-interferon: effect on tumor growth in metastatic endocrine gastroenteropancreatic tumors. Am J Gastroenterol, 1999, 94 : 1381-1387.
  • 6Kouvaraki MA, Ajani JA, Hoff P, et al. Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas. J Clin Oncol, 2004,22 : 4762-4771.
  • 7Chow LQ, Eckhardt SG. Sunitinib: from rational design to clinical efficacy. J Clin Oncol, 2007,25:884-896.
  • 8Duran I, Kortmansky J, Singh D, et al. A phase Ⅱ clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas. Br J Cancer, 2006,95 : 1148-1154.
  • 9Rigaud G, Missiaglia E, Moore PS, et al. High resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications. Cancer Res, 2001,61 : 285 -292.
  • 10Wang L, Ignat A, Axiotis CA, et al. Differential expression of the PTEN tumor suppressor protein in fetal and adult neuroendocrine tissues and tumors : progressive loss of PTEN expression in poorly differentiated neuroendocrine neoplasms. Appl Immunohistochem Mol Morphol, 2002,10 : 139-146.

同被引文献13

  • 1陆新良,王小英,钱可大,吴勤动.WERMER综合征一例[J].中华内科杂志,2006,45(1):63-64. 被引量:2
  • 2Oberg K,Eriksson B.Endocrine tumours of the pancreas[J].Best Pract Res Clin Gastroenterol,2005,19(5):753-781.
  • 3Kouvaraki MA,Solorzano CC,Shapiro SE,et al.Surgical treatment of non-functioning pancreatic islet cell tumors[J].J Surg Oncol,2005,89(3):170-185.
  • 4Cryer PE,Axelrod L,Grossman AB,et al.Evaluation and management of adult hypoglycemic disorders:an endocrine society clinical practice guideline[J].J Clin Endocrinol Metab,2009,94(3):709-728.
  • 5Rinke A,Muller HH,Schade-Brittinger C,et al.Placebocontrolled,double-blind,prospective,randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors:a report from the PROMID Study Group[J].J Clin Oncol,2009,27(28):4 656-4 663.
  • 6Rigaud G,Missiaglia E,Moore.PS,et al.High resolution allelotype of nonfunctional pancreatic endocrine tumors:identification of two molecular subgroups with clinical implications[J].Cancer Res,2001,61(1):285-292.
  • 7Kulke MH,Lenz HJ,Meropol NJ,et al.Activity of sunitinib in patients with advanced neuroendocrine tumors[J].J Clin Oncol,2008,26(20):3403-3410.
  • 8赵玉沛.恶性胰腺内分泌肿瘤的诊断与肝转移的外科治疗[J].腹部外科,2008,21(5):272-273. 被引量:6
  • 9胰腺内分泌肿瘤的诊断和外科治疗指南(讨论稿)[J].中华外科杂志,2009,47(5):339-341. 被引量:14
  • 10展翰翔,赵玉沛,张太平,丛林,廖泉,戴梦华.胰岛素瘤患者围手术期血糖变化规律及处理[J].中华肝胆外科杂志,2011,17(1):13-16. 被引量:5

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部